Clinical Trials Browser

Terminated × Interventional × Neurologic Manifestations × Clear all

NCT02343549 2022-11-03

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Phase 2 Terminated

13 enrolled 23 charts

Brain Neoplasms, Neurologic Manifestations

NCT00360828 2017-03-23

Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas

Phase 2 Terminated

10 enrolled 6 charts

Astrocytoma, Brain Neoplasms, Glioma, Neurologic Manifestations, Oligodendroglioma

NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Phase NA Terminated

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases

NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

Phase NA Terminated

2 enrolled 6 charts

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

NCT00879073 2012-12-18

Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors

Phase 1 Terminated

Brain Neoplasms, Neurologic Manifestations

NCT00365222 2009-01-22

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Phase 2 Terminated

Brain Neoplasms, Glioblastoma, Neurologic Manifestations, Gliosarcoma